Studies show good immune response to J&J vaccine
Studies are showing a good immune response to the Johnson & Johnson (J&J) single-dose COVID-19 vaccine. The South African Medical Research Council (SAMRC) collaborated with J&J on the investigator-led collaborative Sisonke Study, which saw close to 500 000 healthcare workers receiving the single-dose vaccine under the Sisonke Study. The lead investigator in…